New FDA guidelines require manufacturers to add boxed warnings to CAR T-cell therapy products.
FDA Warns Drugmakers of Additional Cancer Risks Associated with CAR T-Cell Therapy
Posted on by admin
![](https://onclive.s3.amazonaws.com/onclive_630x1200.png)
1 min read
+ There are no comments
Add yours